Kathleen DeRose - Dec 27, 2022 Form 4 Insider Report for Enfusion, Inc. (ENFN)

Role
Director
Signature
/s/ Matthew Campobasso, as Attorney-in-Fact
Stock symbol
ENFN
Transactions as of
Dec 27, 2022
Transactions value $
$0
Form type
4
Date filed
12/29/2022, 03:26 PM
Previous filing
Jun 17, 2022
Next filing
May 30, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Award $0 +2.79K +9.55% $0.00 32K Dec 27, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan. The RSUs will vest in full as follows: 931, 930 and 930 RSUs will vest on December 27, 2023, 2024 and 2025, respectively.

Remarks:

Exhibit 24 - Power of Attorney